Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men

Atherosclerosis

Volumn 188, Issue 1, 2006, Pages 184-189

  Matsushita, Kunihiro ^a   Yatsuya, Hiroshi ^a   Tamakoshi, Koji ^a   Wada, Keiko ^a   Otsuka, Rei ^a   Zhang, Huiming ^a   Sugiura, Kaichiro ^a   Kondo, Takahisa ^a   Murohara, Toyoaki ^a   Toyoshima, Hideaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; C reactive protein; Cardiovascular disease; Insulin resistance; Metabolic syndrome

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN;

ADULT; AGED; ANAMNESIS; ANTHROPOMETRY; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MULTIPLE REGRESSION; PRIORITY JOURNAL; SEROLOGY;

ADIPONECTIN; ADULT; AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; HUMANS; INFLAMMATION; JAPAN; MALE; MIDDLE AGED;

EID: 33746561419     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.10.031     Document Type: Article

References (40)

1. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
2. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
3. Xydakis A.M., Case C.C., Jones P.H., et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 89 (2004) 2697-2703
4. Ouchi N., Kihara S., Funahashi T., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
5. Krakoff J., Funahashi T., Stehouwer C.D., et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26 (2003) 1745-1751
6. Daimon M., Yamaguchi H., Oizumi T., et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. Diabetes Care 26 (2003) 2015-2020
7. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360 (2002) 57-58
8. Snehalatha C., Mukesh B., Simon M., et al. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 26 (2003) 3226-3229
9. Choi K.M., Lee J., Lee K.W., et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol 61 (2004) 75-80
10. Pischon T., Girman C.J., Hotamisligil G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. J Am Med Assoc 291 (2004) 1730-1737
11. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
12. Schulze M.B., Shai I., Rimm E.B., et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54 (2005) 534-539
13. Pradhan A.D., and Ridker P.M. Do atherosclerosis and type 2 diabetes share a common inflammatory basis?. Eur Heart J 23 (2002) 831-834
14. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., and Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc 286 (2001) 327-334
15. Ridker P.M., Wilson P.W., and Grundy S.M. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?. Circulation 109 (2004) 2818-2825
16. Engeli S., Feldpausch M., Gorzelniak K., et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52 (2003) 942-947
17. Schulze M.B., Rifai N., Rimm E.B., Hu F.B., and Shai I. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 27 (2004) 1680-1687
18. Mantzoros C.S., Li T., Manson J.E., Meigs J.B., and Hu F.B. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 90 (2005) 4542-4548
19. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., and Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27 (2004) 2450-2457
20. Winzer C., Wagner O., Festa A., et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27 (2004) 1721-1727
21. Rothenbacher D., Brenner H., März W., and Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 26 (2005) 1640-1646
22. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143-421.
23. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'Obesity Disease' in Japan. Circ J 2002;66:987-92.
24. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
25. Lee C.T., Lee C.H., Su Y., et al. The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients. Int J Artif Organs 27 (2004) 835-841
26. Ignacy W., Chudek J., Adamczak M., et al. Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease-a follow-up study. Nephron Clin Pract 101 (2005) c18-c24
27. Higashiura K., Ura N., Ohata J., et al. Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol 61 (2004) 753-759
28. Behre C.J., Fagerberg B., Hultén L.M., and Hulthe J. The reciprocal association of adipocytokines with insulin resistance and C-reactive protein in clinically healthy men. Metabolism 54 (2005) 439-444
29. Yamada S., Gotoh T., Nakashima Y., et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population. Jichi Medical School Cohort Study. Am J Epidemiol 153 (2001) 1183-1190
30. Nakanishi S., Yamane K., Kamei N., Okubo M., and Kohno N. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26 (2003) 2754-2757
31. Sakkinen P., Abbott R.D., Curb J.D., et al. C-reactive protein and myocardial infarction. J Clin Epidemiol 55 (2002) 445-451
32. Ouchi N., Kihara S., Arita Y., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
33. Agrawal A., Cha-Molstad H., Samols D., and Kushner I. Overexpressed nuclear factor-κB can participate in endogeneous C-reactive protein induction, and enhances the effects of C/EBPβ and signal transducer and activator of transcription-3. Immunology 108 (2003) 539-547
34. Zwaka T.P., Hombach V., and Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages. Implications for atherosclerosis. Circulation 103 (2001) 1194-1197
35. Bruun J.M., Lihn A.S., Verdich C., et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285 (2003) E527-E533
36. Fasshauer M., Kralisch S., Klier M., et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 301 (2003) 1045-1050
37. Miyazaki T., Shimada K., Mokuno H., and Daida H. Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease. Heart 89 (2003) 663-664
38. Ohashi K., Ouchi N., Kihara S., et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 43 (2004) 1195-1200
39. Tschritter O., Fritsche A., Thamer C., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52 (2003) 239-243
40. Malik S., Wong N.D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250